Linus Health is a digital health startup that operates in the cognitive care sector, with a focus on early detection and intervention of Alzheimer's and other forms of dementia. The company leverages artificial intelligence (AI) to enhance cognitive assessments, which helps healthcare providers identify early signs of cognitive impairment more efficiently. This opens a new window of opportunity for early intervention, potentially changing the prognosis for patients.

The company's primary offering is a next-generation digital cognitive assessment platform. This platform combines long-established cognitive assessments with a process-based approach to neurological analysis, all enhanced by AI. The result is a scientifically-validated, efficient method for early detection of cognitive impairment.

Linus Health's platform is designed with the realities of clinical care and research in mind. It offers iPad-based assessments that are quick to administer, standardized administration and automated scoring, multi-language support, integrated clinical decision support, and personalized patient action plans.

The company's flagship solution, DCTclock, is an AI-enhanced upgrade to the traditional clock drawing test. This technology, which has been extensively researched and widely published, was developed over a decade at MIT and Lahey.

Linus Health operates in a market with a growing need for its services, as the number of dementia cases worldwide is projected to rise significantly by 2050. The company's business model is likely based on selling its platform and services to healthcare providers and research institutions.

Keywords: Digital Health, Cognitive Care, Alzheimer's, Dementia, Early Detection, Artificial Intelligence, Cognitive Assessments, Neurological Analysis, Healthcare Providers, Clinical Research.